HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
RCT
Estetrol 15 mg and 20 mg reduce vasomotor symptom frequency and severity in postmenopausal women
Estetrol reduces hot flashes in women with and without hysterectomies
This phase 3 randomized, double-blind, placebo-controlled trial enrolled 640 hysterectomized and non-hysterectomized participants aged 40 to…
A phase 3 trial found that estetrol significantly reduced the frequency and severity of moderate to severe vasomotor symptoms in postmenopau…
Jun 1, 2026
Diabetes & Endocrinology
Sys. Review
Systematic review finds no progestogen class effect in oral contraception, with varying safety profiles
A Safer Pill? How a New Generation of Birth Control May Lower Your Risk
A systematic review of oral contraception in women found no class effect among progestogens.
New birth control pills using natural estrogens may lower blood clot risks compared to older versions, offering a safer option for millions …
Frontiers
Apr 12, 2026